scispace - formally typeset
G

Glykeria Tzatzagou

Publications -  4
Citations -  286

Glykeria Tzatzagou is an academic researcher. The author has contributed to research in topics: Urokinase & Anakinra. The author has an hindex of 2, co-authored 4 publications receiving 25 citations.

Papers
More filters
Journal ArticleDOI

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Evdoxia Kyriazopoulou, +64 more
- 03 Sep 2021 - 
TL;DR: The SAVE-MORE trial as discussed by the authors evaluated the efficacy and safety of anakinra, an IL-1α/β inhibitor, in 594 patients with COVID-19 at risk of progressing to respiratory failure.
Journal ArticleDOI

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Evdoxia Kyriazopoulou, +64 more
- 01 Oct 2021 - 
Posted ContentDOI

Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

TL;DR: The SAVE-MORE trial as discussed by the authors showed that early anakinra treatment guided by elevated soluble urokinase plasminogen activator receptor (suPAR) prevented progression of COVID-19 pneumonia into respiratory failure.
Posted ContentDOI

Early Treatment of COVID-19 Pneumonia with Anakinra Guided by Urokinase Plasminogen Receptor

TL;DR: Early recognition of risk and start of treatment may improve unfavorable outcome of COVID-19, double-blind randomized trial of pneumonia without respiratory dysfunction at risk as defined by plasma suPAR.